Market Wire - Transdel Pharmaceuticals Submits to the FDA the Phase 3 Clinical Study of Ketotransdel(TM) for the Treatment of Acute Pain
Published on: Thu, 07 Feb 2008 08:00:00 GMT
February 7, 2008 -- Transdel Pharmaceuticals, Inc. (OTCBB: TDLP),a specialty pharmaceutical company focused on the development andcommercialization of non-invasive... More »
